{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:54Z","timestamp":1792782714220,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Adelaide University","id":[{"id":"https:\/\/ror.org\/028g18b61","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The gut microbiome has gained increasing recognition as an important factor influencing cancer treatment efficacy and toxicity. However, translation of this knowledge to deliver clinical benefit has been hampered by inconsistent approaches to both biospecimen sampling and investigation of microbial-based interventions, potentially reflecting inherent biases and\/or barriers across research environments. Accordingly, we aimed to characterize the current practices and perceptions surrounding the gut microbiome among members of the Multinational Association of Supportive Care in Cancer (MASCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mixed-methods survey, probing current research and\/or clinical use, plans, and perceptions of the gut microbiome in oncology, was developed in 2022 and distributed MASCC-wide via REDCap. Quantitative data were summarized using descriptive analyses, and qualitative responses were independently dual-coded using inductive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 117 respondents, the majority (83%) held the belief that the gut microbiome plays an important role in disease states such as cancer. 44.4% of survey respondents reported ongoing research or clinical practice regarding the gut microbiome at their center, with 70.5% also expressing an interest in developing such a program. Qualitative analysis revealed 6 main themes: (1) state of the evidence, (2) significance of the microbiome, (3) uncertainty, (4) aspirations, (5) preferences, and (6) critique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This survey identifies general concordance on the importance of the gut microbiome in cancer. Despite interest in this field, there is a clear need for resource support (i.e., funding and infrastructure) and increased expertise to support high-quality trials generating the evidence required for implementation of microbial-based sampling or therapeutics in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11042-w","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:52:53Z","timestamp":1786521173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use, understanding, and perceptions of gut microbiome research and practices in oncology"],"prefix":"10.1007","volume":"34","author":[{"given":"Courtney B.","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya R.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Irestorm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton P.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin W.","family":"Elgarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah R.","family":"Wardill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison T.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Ting","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dori M.","family":"Beeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"1","key":"11042_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40168-025-02091-0","volume":"13","author":"LB Bindels","year":"2025","unstructured":"Bindels LB, Watts JEM, Theis KR, Carrion VJ, Ossowicki A, Seifert J et al (2025) A blueprint for contemporary studies of microbiomes. Microbiome 13(1):95","journal-title":"Microbiome"},{"issue":"7484","key":"11042_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484):559\u2013563","journal-title":"Nature"},{"key":"11042_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.724449","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Li L, Jin B, Xu X, Zuo X, Li Y, Li Z (2021) The effects of delivery mode on the gut microbiota and health: state of art. Front Microbiol 12:724449","journal-title":"Front Microbiol"},{"issue":"5","key":"11042_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s42255-025-01287-w","volume":"7","author":"A Nobels","year":"2025","unstructured":"Nobels A, van Marcke C, Jordan BF, Van Hul M, Cani PD (2025) The gut microbiome and cancer: from tumorigenesis to therapy. Nat Metab 7(5):895\u2013917","journal-title":"Nat Metab"},{"issue":"1","key":"11042_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12866-021-02153-x","volume":"21","author":"M Loftus","year":"2021","unstructured":"Loftus M, Hassouneh SA, Yooseph S (2021) Bacterial community structure alterations within the colorectal cancer gut microbiome. BMC Microbiol 21(1):98","journal-title":"BMC Microbiol"},{"issue":"12","key":"11042_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G (2022) Targeting the gut microbiota for cancer therapy. Nat Rev Cancer 22(12):703\u2013722","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"11042_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14092982","volume":"14","author":"IG Dumitru","year":"2025","unstructured":"Dumitru IG, Todor SB, Ichim C, Helgiu C, Helgiu A (2025) A literature review on the impact of the gut microbiome on cancer treatment efficacy, disease evolution and toxicity: the implications for hematological malignancies. J Clin Med 14(9):2982","journal-title":"J Clin Med"},{"issue":"7","key":"11042_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071252","volume":"17","author":"K Kim","year":"2025","unstructured":"Kim K, Lee M, Shin Y, Lee Y, Kim T-J (2025) Optimizing cancer treatment through gut microbiome modulation. Cancers (Basel) 17(7):1252","journal-title":"Cancers (Basel)"},{"issue":"6371","key":"11042_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science (New York, NY) 359(6371):97\u2013103","journal-title":"Science (New York, NY)"},{"issue":"6529","key":"11042_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L et al (2021) Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science 371(6529):602\u2013609","journal-title":"Science"},{"issue":"6529","key":"11042_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM et al (2021) Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science 371(6529):595\u2013602","journal-title":"Science"},{"issue":"8","key":"11042_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00520-024-08752-4","volume":"32","author":"AM Stringer","year":"2024","unstructured":"Stringer AM, Hargreaves BM, Mendes RA, Blijlevens NMA, Bruno JS, Joyce P et al (2024) Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC\/ISOO framework. Supportive care in cancer\u202f: official journal of the Multinational Association of Supportive Care in Cancer 32(8):558","journal-title":"Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer"},{"key":"11042_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119592","author":"NMA Blijlevens","year":"2023","unstructured":"Blijlevens NMA, de Mooij CEM (2023) Mucositis and infection in hematology patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24119592","journal-title":"Int J Mol Sci"},{"key":"11042_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neubiorev.2020.07.002","volume":"116","author":"CB Subramaniam","year":"2020","unstructured":"Subramaniam CB, Bowen JM, Gladman MA, Lustberg MB, Mayo SJ, Wardill HR (2020) The microbiota-gut-brain axis: an emerging therapeutic target in chemotherapy-induced cognitive impairment. Neurosci Biobehav Rev 116:470\u2013479","journal-title":"Neurosci Biobehav Rev"},{"key":"11042_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbi.2024.05.039","volume":"120","author":"LD Otto-Dobos","year":"2024","unstructured":"Otto-Dobos LD, Grant CV, Lahoud AA, Wilcox OR, Strehle LD, Loman BR et al (2024) Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain Behav Immun 120:208\u2013220","journal-title":"Brain Behav Immun"},{"key":"11042_CR16","unstructured":"Lumivero. NVivo (Version 15) 2022.\u00a0https:\/\/www.lumivero.com\/nvivo"},{"issue":"2","key":"11042_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1525822X19838237","volume":"31","author":"MA Cascio","year":"2019","unstructured":"Cascio MA, Lee E, Vaudrin N, Freedman DA (2019) A team-based approach to open coding: considerations for creating intercoder consensus. Field Methods 31(2):116\u2013130","journal-title":"Field Methods"},{"issue":"11","key":"11042_CR18","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.cell.2025.04.016","volume":"188","author":"S Porcari","year":"2025","unstructured":"Porcari S, Ng SC, Zitvogel L, Sokol H, Weersma RK, Elinav E et al (2025) The microbiome for clinicians. Cell 188(11):2836\u201344","journal-title":"Cell"},{"key":"11042_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11020100","author":"A Pession","year":"2021","unstructured":"Pession A, Zama D, Muratore E, Leardini D, Gori D, Guaraldi F et al (2021) Fecal microbiota transplantation in allogeneic hematopoietic stem cell transplantation recipients: a systematic review. J Pers Med. https:\/\/doi.org\/10.3390\/jpm11020100","journal-title":"J Pers Med"},{"key":"11042_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ebiom.2019.03.070","volume":"44","author":"HR Wardill","year":"2019","unstructured":"Wardill HR, Secombe KR, Bryant RV, Hazenberg MD, Costello SP (2019) Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine 44:730\u2013740","journal-title":"EBioMedicine"},{"issue":"9","key":"11042_CR21","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.bbmt.2020.05.011","volume":"26","author":"M Gavriilaki","year":"2020","unstructured":"Gavriilaki M, Sakellari I, Anagnostopoulos A, Gavriilaki E (2020) The impact of antibiotic-mediated modification of the intestinal microbiome on outcomes of allogeneic hematopoietic cell transplantation: systematic review and meta-analysis. Biol Blood Marrow Transplant 26(9):1738\u20131746","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"11042_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S1470-2045(23)00182-1","volume":"24","author":"SA McIntosh","year":"2023","unstructured":"McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I et al (2023) Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments. Lancet Oncol 24(6):636\u2013645","journal-title":"Lancet Oncol"},{"key":"11042_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1643257","volume":"16","author":"E Garcia-Gutierrez","year":"2025","unstructured":"Garcia-Gutierrez E, Arbulu S, Oliver C, Kumar S, Dam SA, Jakobi B et al (2025) GutMicrobiotAware: an international exploratory survey on awareness and understanding of the gut microbiota. Front Microbiol 16:1643257","journal-title":"Front Microbiol"},{"issue":"1","key":"11042_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12960-017-0218-z","volume":"15","author":"P Chow-White","year":"2017","unstructured":"Chow-White P, Ha D, Laskin J (2017) Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists. Hum Resour Health 15(1):42","journal-title":"Hum Resour Health"},{"issue":"54","key":"11042_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/jncimonographs\/lgz026","volume":"2019","author":"R Bhuta","year":"2019","unstructured":"Bhuta R, Nieder M, Jubelirer T, Ladas EJ (2019) The gut microbiome and pediatric cancer: current research and gaps in knowledge. JNCI Monographs 2019(54):169\u2013173","journal-title":"JNCI Monographs"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11042-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11042-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11042-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:02:26Z","timestamp":1790362946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11042-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["11042"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11042-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at the Children\u2019s Hospital of Philadelphia and was deemed exempt from full review (IRB 22-019620). The study was reviewed by the Children\u2019s Hospital of Philadelphia Institutional Review Board and was considered exempt from a written consent requirement or ongoing IRB oversight.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"843"}}